A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss.
A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss.
复制标题
DOI：
10.3389/froh.2021.686402
复制
发表时间：
2021
影响因子：
--
通讯作者：
Gibson FC 3rd
中科院分区：
文献类型：
--
作者：
Rocha FG;Berges A;Sedra A;Ghods S;Kapoor N;Pill L;Davey ME;Fairman J;Gibson FC 3rd
Periodontal diseases are chronic inflammatory diseases of the periodontium that result in progressive destruction of the soft and hard tissues supporting the teeth, and it is the most common cause of tooth loss among adults. In the US alone, over 100 million individuals are estimated to have periodontal disease. Subgingival bacteria initiate and sustain inflammation, and, although several bacteria have been associated with periodontitis, Porphyromonas gingivalis has emerged as the key etiological organism significantly contributing to the disease. Currently, intensive clinical maintenance strategies are deployed to mitigate the further progression of disease in afflicted individuals; however, these treatments often fail to stop disease progression, and, as such, the development of an effective vaccine for periodontal disease is highly desirable. We generated a conjugate vaccine, comprising of the purified capsular polysaccharide of P. gingivalis conjugated to eCRM®, a proprietary and enhanced version of the CRM197 carrier protein with predetermined conjugation sites (Pg-CV). Mice immunized with alum adjuvanted Pg-CV developed robust serum levels of whole organism-specific IgG in comparison to animals immunized with unconjugated capsular polysaccharide alone. Using the murine oral bone loss model, we observed that mice immunized with the capsule-conjugate vaccine were significantly protected from the effects of P. gingivalis-elicited oral bone loss. Employing a preclinical model of infection-elicited oral bone loss, our data support that a conjugate vaccine incorporating capsular polysaccharide antigen is effective in reducing the main clinical endpoint of periodontal disease—oral bone destruction. Further development of a P. gingivalis capsule-based conjugate vaccine for preventing periodontal diseases is supported.
登录
查看更多内容
影响因子：
4.6
作者：
Herath TDK;Darveau RP;Seneviratne CJ;Wang CY;Wang Y;Jin L
通讯作者：
Jin L
影响因子：
2.9
作者：
Kendrick, BS;Kerwin, BA;Philo, JS
通讯作者：
Philo, JS
影响因子：
3.1
作者：
d'Empaire, Gabriela;Baer, Michael T.;Gibson, Frank C., III
通讯作者：
Gibson, Frank C., III
影响因子：
3
作者：
BAKER, PJ;EVANS, RT;ROOPENIAN, DC
通讯作者：
ROOPENIAN, DC
影响因子：
3.1
作者：
Gibson, FC;Genco, CA
通讯作者：
Genco, CA